Gene · 4627
Papers4,242
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
741 to 760 of 4,242
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Dysregulated Expression of MiR-19b, MiR-25, MiR-17, WT1, and CEBPA in Patients with Acute Myeloid Leukemia and Association with Graft versus Host Disease after Hematopoietic Stem Cell Transplantation. | South Asian J Cancer | 2022 | 36756106 | PubTator, text mining | PubMed |
| USP6-associated soft tissue tumors with bone metaplasia: Clinicopathologic and genetic analysis and the identification of novel USP6 fusion partners. | Front Oncol | 2022 | 36727055 | PubTator, text mining | PubMed |
| Estimating the future global dose demand for measles-rubella microarray patches. | Front Public Health | 2022 | 36726626 | PubTator, text mining | PubMed |
| Novel variants of NEK9 associated with neonatal arthrogryposis: Two case reports and a literature review. | Front Genet | 2022 | 36712877 | PubTator, text mining | PubMed |
| Perioperative corticosteroid treatment impairs tumor-infiltrating dendritic cells in patients with newly diagnosed adult-type diffuse gliomas. | Front Immunol | 2022 | 36703985 | PubTator, text mining | PubMed |
| Long noncoding RNA BBOX1-AS1 promotes the progression of gastric cancer by regulating the miR-361-3p/Mucin 13 signaling axis. | Bioengineered | 2022 | 36700475 | PubTator, text mining | PubMed |
| Identification and comprehensive analysis of circRNA-miRNA-mRNA regulatory networks in osteoarthritis. | Front Immunol | 2022 | 36700234 | PubTator, text mining | PubMed |
| Negative Molecular Diagnostics in Non-Syndromic Hearing Loss: What Next? | Genes (Basel) | 2022 | 36672845 | PubTator, text mining | PubMed |
| Integrated Profiles of Transcriptome and mRNA m6A Modification Reveal the Intestinal Cytotoxicity of Aflatoxin B1 on HCT116 Cells. | Genes (Basel) | 2022 | 36672820 | PubTator, text mining | PubMed |
| Renal Papillary Necrosis (RPN) in an African Population: Disease Patterns, Relevant Pathways, and Management. | Biomedicines | 2022 | 36672600 | PubTator, text mining | PubMed |
| Cells Responding to Closely Related Cholesterol-Dependent Cytolysins Release Extracellular Vesicles with a Common Proteomic Content Including Membrane Repair Proteins. | Toxins (Basel) | 2022 | 36668824 | PubTator, text mining | PubMed |
| Systems biology and in silico-based analysis of PCOS revealed the risk of metabolic disorders. | Heliyon | 2022 | 36619413 | PubTator, text mining | PubMed |
Multi-omics analyses of tumor-associated immune-infiltrating cells with the novel immune checkpoint protein tyrosine phosphatase 1B (PTP1B) in extracellular matrix of brain-lower-grade-glioma (LGG) and uveal-melanoma (UVM). | Front Immunol | 2022 | 36618415 | PubTator, text mining | PubMed |
| Neuronal and Glial Communication via Non-Coding RNAs: Messages in Extracellular Vesicles. | Int J Mol Sci | 2022 | 36613914 | PubTator, text mining | PubMed |
| Multifaceted Pharmacological Potentials of Curcumin, Genistein, and Tanshinone IIA through Proteomic Approaches: An In-Depth Review. | Cancers (Basel) | 2022 | 36612248 | PubTator, text mining | PubMed |
| Actin-Myosin Cytoskeleton Regulation and Function. | Cells | 2022 | 36611802 | PubTator, text mining | PubMed |
| Detection of ROS1 gene fusions using next-generation sequencing for patients with malignancy in China. | Front Cell Dev Biol | 2022 | 36589752 | PubTator, text mining | PubMed |
| Audiological Evidence of Frequent Hereditary Mild, Moderate and Moderate-to-Severe Hearing Loss. | J Pers Med | 2022 | 36579563 | PubTator, text mining | PubMed |
| Does particle radiation have superior radiobiological advantages for prostate cancer cells? A systematic review of in vitro studies. | Eur J Med Res | 2022 | 36572945 | PubTator, text mining | PubMed |
| Agronomic biofortification of food crops: An emerging opportunity for global food and nutritional security. | Front Plant Sci | 2022 | 36570883 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4627/papers?page=38